Drug Pipeline

Bulevirtide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
6
Recruiting
5
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 3
3
Phase 2/3
2
Phase 2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07298330 A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis… Chronic Hepatitis D Infection Recruiting
NCT07200908 A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic… Chronic Hepatitis D Infection Recruiting
NCT07128550 A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not… Viral Hepatitis Recruiting
Phase 2/3
NCT07454837 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants… Chronic Hepatitis D Recruiting
NCT06907290 A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis… Chronic Hepatitis D Infection Active, Not Recruiting
Phase 2
NCT07142811 A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection Viral Hepatitis Active, Not Recruiting
Not specified
NCT06504485 Immunological and Virological Characterization of Patients With Chronic HBV-HDV… Hepatitis D Recruiting
NCT07491848 Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With… HEPATITIS B CHRONIC Recruiting
Sponsors Running Bulevirtide Trials
Get alerts when Bulevirtide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free